(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -163.84%-556.16M | ---- | -80.68%871.15M | ---- | 271.69%4.51B | ---- | 45.46%1.21B | ---- | 780.61%834.14M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -133.96%-57.39M | ---- | -86.16%-24.53M | ---- | 27.80%-13.18M | ---- | -113.93%-18.25M | ---- | -30.74%-8.53M |
Attributable subsidiary (profit) loss | ---- | 2.97%-527.19M | ---- | -10.30%-543.32M | ---- | -84.90%-492.57M | ---- | 22.13%-266.39M | ---- | -87.63%-342.11M |
Impairment and provisions: | ---- | 52.35%697.06M | ---- | 480.51%457.53M | ---- | -48.49%78.82M | ---- | 16.59%153M | ---- | 639.84%131.23M |
-Impairment of property, plant and equipment (reversal) | ---- | 89.04%121.52M | ---- | 300.58%64.29M | ---- | 217.53%16.05M | ---- | --5.05M | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | 66.01%78.09M | ---- | 5,622.26%47.04M | ---- | 114.18%822K | ---- | ---5.8M | ---- | ---- |
-Other impairments and provisions | ---- | 43.69%497.45M | ---- | 458.90%346.21M | ---- | -59.71%61.95M | ---- | 17.15%153.74M | ---- | 639.84%131.23M |
Revaluation surplus: | ---- | 199.33%37.31M | ---- | 113.13%12.46M | ---- | -4,170.81%-94.94M | ---- | 96.70%-2.22M | ---- | -1,774.02%-67.33M |
-Fair value of investment properties (increase) | ---- | 127.36%2.9M | ---- | 85.83%-10.6M | ---- | -5,445.00%-74.83M | ---- | 403.69%1.4M | ---- | -168.09%-461K |
-Derivative financial instruments fair value (increase) | ---- | 249.35%34.41M | ---- | ---23.04M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | 329.25%46.1M | ---- | -455.06%-20.11M | ---- | 94.58%-3.62M | ---- | -3,690.70%-66.87M |
Asset sale loss (gain): | ---- | -16.83%12.22M | ---- | 100.43%14.7M | ---- | -234.36%-3.39B | ---- | -28.66%-1.01B | ---- | -430,126.78%-787.32M |
-Loss (gain) from sale of subsidiary company | ---- | ---2.66M | ---- | ---- | ---- | -231.54%-3.39B | ---- | -29.92%-1.02B | ---- | ---787.4M |
-Loss (gain) on sale of property, machinery and equipment | ---- | 46.98%12.57M | ---- | 78.93%8.55M | ---- | 78.36%4.78M | ---- | 3,250.00%2.68M | ---- | 143.72%80K |
-Loss (gain) from selling other assets | ---- | -62.32%2.31M | ---- | --6.14M | ---- | ---- | ---- | --7.39M | ---- | ---- |
Depreciation and amortization: | ---- | 62.91%814.06M | ---- | 159.33%499.71M | ---- | 49.16%192.69M | ---- | 274.85%129.19M | ---- | 652.47%34.46M |
-Depreciation | ---- | 59.68%639.19M | ---- | 149.65%400.3M | ---- | 68.70%160.34M | ---- | 375.13%95.05M | ---- | 376.29%20M |
-Amortization of intangible assets | ---- | 75.90%174.88M | ---- | 207.30%99.42M | ---- | -5.24%32.35M | ---- | 136.12%34.14M | ---- | 3,705.00%14.46M |
Financial expense | ---- | 124.90%130M | ---- | 56.02%57.8M | ---- | -43.12%37.05M | ---- | -44.95%65.14M | ---- | 41.39%118.33M |
Special items | ---- | 97.90%-20.12M | ---- | -1.93%-959.82M | ---- | -293.26%-941.61M | ---- | -2,407.39%-239.44M | ---- | -21.08%10.38M |
Operating profit before the change of operating capital | ---- | 37.36%529.8M | ---- | 448.74%385.69M | ---- | -615.47%-110.59M | ---- | 127.96%21.46M | ---- | -365.85%-76.74M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 314.94%629.42M | ---- | -215.47%-292.84M | ---- | -311.82%-92.83M | ---- | 12,341.34%43.82M | ---- | 89.70%-358K |
Accounts receivable (increase)decrease | ---- | 70.02%51.8M | ---- | 1,197.55%30.47M | ---- | -101.56%-2.78M | ---- | -1.90%178.07M | ---- | 326.63%181.53M |
Accounts payable increase (decrease) | ---- | -414.15%-464.67M | ---- | -147.57%-90.38M | ---- | 362.57%190M | ---- | 143.81%41.08M | ---- | -49.94%-93.76M |
prepayments (increase)decrease | ---- | -70.27%53.92M | ---- | 902.54%181.38M | ---- | 1,356.39%18.09M | ---- | -102.21%-1.44M | ---- | 5,031.62%65.2M |
Derivative financial instruments (increase) decrease | ---- | --28.45M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --22.78M |
Special items for working capital changes | ---- | -299.27%-74.18M | ---- | -99.55%-18.58M | ---- | -128.02%-9.31M | ---- | 189.72%33.23M | ---- | -675.79%-37.04M |
Cash from business operations | 88.80%-38.43M | 285.47%754.54M | -19.01%-343.09M | 2,740.19%195.74M | -2,884.58%-288.28M | -102.34%-7.41M | ---9.66M | 413.30%316.21M | ---- | 154.94%61.6M |
Other taxs | 45.44%-40.27M | -1.50%-122.65M | -606.94%-73.8M | -298.46%-120.84M | 46.62%-10.44M | -38.89%-30.33M | ---19.56M | -7.56%-21.83M | ---- | 30.09%-20.3M |
Special items of business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -106.51%-4.42M | ---- |
Net cash from operations | 81.12%-78.7M | 743.56%631.89M | -39.56%-416.89M | 298.48%74.91M | -922.45%-298.72M | -112.82%-37.74M | -561.00%-29.22M | 612.71%294.38M | -106.51%-4.42M | 129.26%41.3M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -6.93%21.67M | 169.39%57.51M | 370.34%23.28M | 62.02%21.35M | -16.22%4.95M | -14.72%13.18M | --5.91M | 62.63%15.45M | ---- | 110.64%9.5M |
Dividend received - investment | -59.66%55.4M | 63.01%273.75M | -5.26%137.34M | 104.18%167.93M | 115.00%144.96M | 20.85%82.25M | --67.42M | 34.71%68.06M | ---- | 345.41%50.52M |
Decrease in deposits (increase) | ---- | --1.11M | -5,501.32%-34M | ---- | 99.80%-607K | ---4.28M | ---300M | ---- | ---- | ---- |
Sale of fixed assets | --26K | 208.46%21.03M | ---- | -41.84%6.82M | --874K | 326.33%11.72M | ---- | 733.33%2.75M | ---- | -42.81%330K |
Purchase of fixed assets | 0.83%-92.78M | -17.81%-216.07M | -114.05%-93.55M | -102.80%-183.41M | -120.66%-43.71M | -291.87%-90.44M | ---19.81M | -117.93%-23.08M | ---- | -35.79%-10.59M |
Purchase of intangible assets | 58.66%-62.58M | -258.20%-336.66M | ---151.37M | -2,817.04%-93.99M | ---- | 56.00%-3.22M | ---814K | -34.08%-7.32M | ---- | ---5.46M |
Sale of subsidiaries | ---- | ---4.87M | ---5.17M | ---- | ---- | 177.95%4.15B | --4.11B | -17.73%1.49B | ---- | --1.82B |
Acquisition of subsidiaries | ---- | -100.97%-9.03M | 76.82%-9.03M | --928.63M | ---38.97M | ---- | ---- | 146.90%124.1M | ---- | -7,666.28%-264.6M |
Recovery of cash from investments | ---- | ---- | ---- | --183.12M | --183.12M | ---- | ---- | ---- | ---- | ---- |
Cash on investment | ---51.73M | 64.02%-17.4M | ---- | 80.90%-48.36M | ---- | ---253.18M | ---- | ---- | ---- | ---- |
Other items in the investment business | 78.03%-34.9M | -1,229.41%-167.9M | -1,077.17%-158.86M | 95.97%-12.63M | 95.48%-13.5M | -15.14%-313.03M | -119.22%-298.49M | ---271.87M | -6.42%1.55B | ---- |
Net cash from investment operations | 43.41%-164.89M | -141.11%-398.53M | -222.88%-291.38M | -73.03%969.46M | -93.35%237.13M | 156.43%3.59B | 129.69%3.57B | -12.13%1.4B | -6.42%1.55B | 2,680.07%1.6B |
Net cash before financing | 65.61%-243.59M | -77.66%233.36M | -1,049.91%-708.27M | -70.63%1.04B | -101.74%-61.59M | 109.70%3.56B | 128.46%3.54B | 3.64%1.7B | -10.35%1.55B | 2,052.98%1.64B |
Cash flow from financing activities | ||||||||||
New borrowing | 108.56%2.36B | 171.46%2.44B | 8,075.66%1.13B | --900.61M | --13.84M | ---- | ---- | ---- | ---- | 3,040.00%1.26B |
Refund | -137.52%-1.62B | -132.40%-2.58B | -19,989.19%-681.83M | 11.68%-1.11B | 99.73%-3.39M | -2,190.76%-1.26B | ---1.26B | -37.07%-54.83M | ---- | 2.62%-40M |
Issuing shares | -96.25%1M | -32.81%28.05M | -10.32%26.72M | 28.65%41.75M | 32.18%29.8M | --32.45M | --22.54M | ---- | ---- | -56.96%9.2M |
Interest paid - financing | 24.44%-16.22M | -837.31%-66.27M | ---21.47M | 56.03%-7.07M | ---- | 66.46%-16.08M | ---15.89M | 61.35%-47.94M | ---- | -206.03%-124.03M |
Dividends paid - financing | ---- | ---- | ---- | 96.94%-47.36M | ---- | -419.01%-1.55B | ---14.23M | 82.09%-298.51M | ---- | ---1.67B |
Absorb investment income | ---- | 849.77%54.86M | 1,392.73%54.86M | -91.70%5.78M | -94.43%3.68M | 1,757.94%69.58M | --65.98M | --3.75M | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---778M |
Other items of the financing business | ---- | ---1.08B | ---1.08B | ---- | ---- | ---- | 94.80%-1.84M | ---- | 97.90%-35.41M | ---- |
Net cash from financing operations | 141.11%373.5M | -222.63%-1.9B | -1,975.92%-908.63M | 79.57%-589.98M | 96.63%-43.77M | -476.28%-2.89B | -3,569.10%-1.3B | 62.99%-501.22M | 97.90%-35.41M | -6,592.85%-1.35B |
Effect of rate | -78.00%20.8M | 118.89%10.18M | 481.60%94.51M | -1,345.10%-53.86M | -1,314.66%-24.77M | -67.86%4.33M | 133.81%2.04M | 198.59%13.46M | -161.95%-6.03M | 62.43%-13.65M |
Net Cash | 108.03%129.92M | -467.55%-1.67B | -1,434.60%-1.62B | -31.97%454.39M | -104.71%-105.36M | -44.10%667.9M | 47.95%2.24B | 323.27%1.19B | 3,429.48%1.51B | 371.34%282.26M |
Begining period cash | -56.65%1.27B | 15.83%2.93B | 15.83%2.93B | 36.19%2.53B | 36.19%2.53B | 186.08%1.86B | 186.08%1.86B | 70.56%649.26M | 70.56%649.26M | -26.94%380.65M |
Cash at the end | 0.94%1.42B | -56.65%1.27B | -41.33%1.41B | 15.83%2.93B | -41.45%2.4B | 36.19%2.53B | 90.04%4.1B | 186.08%1.86B | 397.77%2.16B | 70.56%649.26M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 96.17%982.54M | ---- | 43.33%500.87M |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 96.17%982.54M | ---- | 43.33%500.87M |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data